From GLP-1 injections to NAD+ infusions, Boston has become ground zero for the longevity obsession—where everyone from Back ...

Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in combination with bortezomib, lenalidomide and ...

The FDA has accepted for review the sBLA for subcutaneous lecanemab-irmb as a weekly starting dose for Alzheimer disease.

The FDA has set a Prescription Drug User Fee Act action date for 24 May 2026.

The FDA approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib (Velcade), lenalidomide ...

For decades, high cholesterol has meant a lifetime of daily pills, repeat blood tests and constant reminders that the biggest ...

“What to do with a spouse who doesn’t imbibe, who doesn’t like crowds or noisy restaurants, and who doesn’t overindulge on sugary desserts? First off, we jettison the traditions that I, too, can live ...

RBI likely to cut repo rate by 0.25% in February, possibly the last cut in this easing cycle. Liquidity injections expected.

Modern technology remains a privilege, not a right, as families of people with diabetes struggle to afford rising ...

Mumbai, Jan 27 (PTI) The Reserve Bank will opt for another 0.25 per cent decrease in key repo rate in its next monetary policy review on February 6, in what is expected to be the last cut in the ...

Infusion therapies can be "life changing" for those suffering from chronic illnesses, founder Shaya Fogel said.